top of page

The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

Aaron Kantoff describes Scion's mission and investment strategy, discusses co-founding RayzeBio, and shares his thoughts on the current state of biotech.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page